Jump to content

Search the hub

Showing results for tags 'Treatment'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Learning news archive
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous
    • Health care
    • Social care
    • Jobs and voluntary positions
    • Suggested resources

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


Join a private group (if appropriate)


About me


Organisation


Role

Found 209 results
  1. News Article
    There has been a 27% rise in people dying while in treatment for drug and alcohol addiction during the pandemic, an official report shows. Changes to support and reduced access to healthcare during lockdowns are likely to have been factors, it says. Between April 2020 and March 2021, 3,726 people died while in contact with drug and alcohol services - up from 2,929 the year before. The figures, published by the Office for Health Improvement and Disparities, for England, show a small 2% rise in the overall numbers of adults receiving help for drug and alcohol problems from 2020 to
  2. News Article
    The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator. The tablet - molnupiravir - will be given twice a day to vulnerable patients recently diagnosed with the disease. In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half. Health Secretary Sajid Javid said the treatment was a "gamechanger" for the most frail and immunosuppressed. In a statement he said: "Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral
  3. News Article
    A health watchdog has scrapped a previous recommendation of graded exercise therapy for ME. The National Institute of Health and Care Excellence (NICE) has published a long-awaited and contentious final update to guidance on treatment. Many patients with ME or chronic fatigue syndrome (CFS) say the therapy, which encourages patients to slowly increase their levels of activity, makes their condition worse. The advice was due out in August, but NICE pulled the publication at the last minute. At that time, NICE said the delay was necessary to allow more conversations with pati
  4. News Article
    Progress in clearing the NHS cancer treatment backlog in England has gone into reverse amid high Covid cases and staff shortages, analysis suggests. The NHS has been striving to catch up with the pandemic backlog of cancer care but the analysis by Macmillan Cancer Support of official data suggests the drive has recently suffered a setback, with growing numbers of potential cancer diagnoses missed. Four key cancer measures have fallen back, with two dropping to their worst ever recorded level. Figures published by NHS England, and analysed by Macmillan for the Guardian, show the
  5. News Article
    One in 10 posts for consultant psychiatrists in England are vacant with growing waiting times for people needing mental health treatment, experts have warned. A census of the current situations across England by the Royal College of Psychiatrists has found there is just one psychiatrist for every 12,567 people in England. Health service bosses at NHS England have acknowledged there are an estimated 1.5 million people who are waiting for mental health support amid fears the situation will worsen as the effects of the Covid pandemic become clear. This is on top of the 5.6 million patie
  6. News Article
    The first new sickle-cell treatment in 20 years will help keep thousands of people out of hospital over the next three years, NHS England has said. Sickle-cell disease is incurable and affects 15,000 people in the UK. And the National Institute for Health and Care Excellence said the hope of reducing health inequalities for black people, who are predominantly affected and often have poorer health to start with, made the drug worth recommending. It called it "an innovative treatment". Read full story Source: BBC News, 5 October 2021
  7. News Article
    It could take more than a decade to clear the cancer-treatment backlog in England, a report suggests. Research by the Institute for Public Policy Research (IPPR) estimated 19,500 people who should have been diagnosed had not been, because of missed referrals. If hospitals could achieve a 5% increase in the number of treatments over pre-pandemic levels, it would take until 2033 to clear the backlog. However, if 15% more could be completed, backlogs could be cleared by next year. Between March 2020 and February 2021, the number of referrals to see a specialist dropped by nearly 3
  8. News Article
    A major acute trust in the East Midlands has been forced to restrict how much chemotherapy it is able to offer due to staff shortages. Nottingham University Hospitals Trust confirmed in a statement its chemotherapy service has been affected by long-term staff sickness and staff vacancies. A trust spokeswoman said: “We continue to provide chemotherapy to patients who benefit most from the treatment and the small number of patients affected have been contacted directly by their specialist cancer team and offered support.” She added: “We are recruiting to posts as well as working
  9. Content Article
    "Several concerns have been raised about the risk of overdose and death from oral morphine sulphate solution over the past few years, but they have gone unheard." In light of coroners reports of deaths related to abuse, or accidental overuse of Oramorph or oral morphine sulphate solution. the author argues for increased regulation. Commenting: "In the absence of any action from ministers, it seems that healthcare professionals are going to have to take the care of vulnerable patients into their own hands." My reflections on this are: Is this a signal for increased regulation or
  10. News Article
    A new campaign to increase awareness of life-saving treatment that can reverse drug overdoses has been launched in Scotland. The Scottish government and Scottish Drugs Forum (SDF) have joined together to help improve information about naloxone which can prevent deaths in the case of opioids overdoses. Drugs policy minister Angela Constance said: “Firstly, on International Overdose Awareness Day I want to pass on my sincere condolences to all those who have been affected by a drug-related death. That is why I am pleased to launch this joint campaign with Scottish Drugs Forum to encour
  11. News Article
    An expensive anti-cholesterol drug called inclisiran could soon be offered to hundreds of thousands of people in England and Wales on the NHS. The drug, which would be administered as a twice-a-year injection, costs around £2,000 per dose, could save about 30,000 lives within a decade. "Inclisiran represents a potential game-changer in preventing thousands of people from dying prematurely from heart attacks and strokes. We're therefore pleased to be able to recommend it as a cost effective option on the NHS." Said Meindert Boysen, NICE deputy chief executive and director of the Centre for
  12. News Article
    With just hours left to go, a health watchdog has paused a final update to ME treatment guidance due to disagreement on some of it's contents. Charities have expressed their anger over this decision as NICE says it needs more discussions with patient groups and professionals so that the advice is supported. Although it is not yet clear when the guidance will be published, the advice on CBT (cognitive behavioural therapy) has been changed as it was only helping with anxiety around the condition rather than the illness itself, with NICE acknowledging the controversy over the best treatment
  13. Content Article
    The risks of targeting the wrong cancer Cancer patients often have to undergo rigorous, exhausting treatments and drug regimes, without achieving the improvements or remission that they seek. This is because certain therapies only work on a particular subset of cancers, based on the specific genetic mutations that the cells contain – if the cancer does not contain such mutations, the drug may be pointless. Moreover, patients who lack the mutation targeted by a drug will not only fail to benefit, but can actually be harmed by inappropriate targeted therapies.[1] Therefore, it is essential
  14. Content Article
    The report from the Pelvic Floor Society proposes changes in six key areas: Empowering and educating patients and beyond. Making use of technology. Integrating expertise. Looking again at surgical procedures. Making the most of our teams. Considering collaborations. Each area is addressed with its own chapter in the report.
×